Featured news and events
The Latest News
February 1, 2017
Michael Beer, an associate professor in the Department of Biomedical Engineering at Johns Hopkins University, has been awarded a $1.8 million grant from the National Institutes of Health as part of the Encyclopedia of DNA Elements Consortium. Read on.
January 27, 2017
Farhad Pashakhanloo's image of the fiber orientation in a human heart was selected from among many entries to appear on the cover of Nature Reviews Cardiology for 12 consecutive months, appearing in a different color each month. Read on.
January 26, 2017
Johns Hopkins researchers report that a new peptide holds promise for improving treatment for degenerative retinal diseases, such as age-related macular degeneration, diabetic macular edema and diabetic retinopathy. These vascular diseases often result in central vision loss as blood vessels grow into tissues at the back of the eye, where such growth should not occur. Read on.
January 23, 2017
Jordan Green, associate professor of biomedical engineering, and his colleagues have figured out a noninvasive way to release and deliver concentrated amounts of a drug to the brain of rats in a temporary, localized manner using ultrasound. Read on.
January 19, 2017
A multicenter team of researchers reports that a full genomic analysis of tumor samples from a small number of people who died of pancreatic cancer suggests that chemical changes to DNA that do not affect the DNA sequence itself yet control how it operates confer survival advantages on subsets of pancreatic cancer cells. Those advantages, the researchers say, let such cancer cells thrive in organs like the liver and lungs, which receive a sugar-rich blood supply. Read on.
January 12, 2017
The Johns Hopkins Center for Bioengineering Innovation and Design, which specializes in medical device design, has launched a one-year gap program with funding for medical students studying at the Johns Hopkins University School of Medicine. Read on.
January 7, 2017
Jordan Green, associate professor of biomedical engineering, and Jonathan Schneck, professor of pathology, both at the School of Medicine, have learned that by combining a biomimetic particle along with a more traditional immunotherapy they could lengthen the lives of mice with skin cancer better than either treatment alone. Both approaches focus on activating the rodent immune system killer T cells — white blood cells that fight infection and other invaders. Read on.
BME in the News — Browse through news coverage Johns Hopkins Department of Biomedical Engineering receives from external sources.